Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Bacigalupo is the Head of the Division of Hematology and Stem Cell Transplants at Ospedale San Martino, Genova, Italy. He graduated in 1973 from the Genova Medical School, Italy, and started an allogeneic transplant program in 1976. He has conducted several clinical trials in patients with aplastic anemia and in patients undergoing allogeneic transplants. His main interests are bone marrow failure, Graft-versus-Host-Disease (GvHD) and related complications, and graft versus leukemia reactions. He has also been interested in cytomegalovirus and Epstein–Barr virus infections, looking at early diagnosis and prospective studies on prophylaxis and pre-emptive therapy. Dr Bacigalupo has served as a board member of the European Group for Bone Marrow Transplantation (EBMT) for several years, as secretary, then Chairperson of the Aplastic Anemia Working Party and then as President from 1998 to 2002. He served as President of the Italian Group of Bone Marrow Transplantation (GITMO) from 2002 to 2005. He has been a member of the Italian National Health Council for two terms (2000–2006). He has served on the Regimen Related Toxicity Working Group of the Center for International Blood and Marrow Transplant Research (CIBMTR).
He is a member of several national and international hematology societies. He is Associate Editor of the journal Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation. He serves on the Board of Haematologica and of the Journal of Clinical Oncology. Dr Bacigalupo has published over 500 articles in peer-reviewed journals.
Jed B. Gorlin
I trained as a pediatric hematologist/oncologist who transitioned to transfusion medicine in1992. I founded the stem cell apheresis and processing and cord blood programs at Boston Children's Hospital, USA and have been at Memorial Blood Centers (now Innovative Blood Resources), Minnsota, USA, since 1997. I served on the AABB board and have an active interest in international transfusion medicine efforts including having done the pre-PEPFAR evaluation of Tanzania for the Centers for Disease Control (CDC) in 2003, given talks at a Pediatric Transfusion PEPFAR conference in Kigali, Rwanda in 2007 and other international presentations in Armenia, Brazil, Egypt and Peru. I moderated the 2010 Workshop to establish blood transfusion guidelines for Rwanda, which were adopted the same year. I presented at 3 Chinese blood centers in anticipation of their hosting the Asian games in Nov 2011. I ran two workshops for transfusion medicine laboratory personnel in Kabul, Afghanistan in February 2011 and June 2012. I am currently scheduled to present in Kazakhstan as a CDC consultant to their centralized blood program. I have maintained an academic link to the University of Minnesota.
Additional AABB service has including participating on Ethics Program unit, Young donors adverse reactions, Cord blood advisory committee and I currently serve as chairs for Interagency task force on donor hemoglobin and iron depletion and International variances from Standards committees.
I currently am also Co-medical Director of the transfusion service of Hennepin County Medical Center, USA, a level one trauma hospital, where I have developed order sets for patients refusing blood, warfarin reversal and massive transfusion. I also developed a self-learning training module on transfusion aspects of obstetric hemorrhage. I am now the AABB liaison to American College of Obstetrics and Gynecology (ACOG), California Maternal Quality Care Collaborative (CMQCC), and the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN).
I am currently PI of a clinical trial measuring blood donor ferritin and providing iron replacement to donors with low ferritin levels.